Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 894

Michael Levin: Cognition and diverse intelligence in non-neural cellular collectives

Consciousness is usually ascribed to a specific set of mechanisms and functional capabilities of the complex brain. Importantly, those mechanisms (ion channels, electrical networks, neurotransmitter machinery) long pre-date the evolutionary innovation of nervous systems. Moreover, the algorithms and competencies such as memory, decision-making, and information integration likewise have an ancient evolutionary origin: before they controlled moving the body through 3D space, electrical networks moved body configurations through anatomical morphospace. In this talk, I will describe how we view the morphogenesis during embryonic development and regeneration as the behavior of a collective intelligence, which has many problem-solving capacities. I will describe the tools we have developed, paralleling neuroscientists’ attempts to read and write mental content by control of electrophysiology, to decode and re-write the pattern memories of the body. This has significant implications not only for biomedicine and evolutionary biology, but also for questions about consciousness and the scaling of coherent Selves from agential materials. I will conclude with some conjectures about what this new field offers the science of consciousness, in the form of new embodied living creatures that are outside the natural evolutionary stream of Earth, and the quest for theories of consciousness.-https://www.drmichaellevin.org/ Participate in our online research survey-Survey on Diverse intelligence-https://tufts.qualtrics.com/jfe/form/SV_eE51vKE34q3hexo (takes 9 minutes). Thank you.

Edited by Emilio Manzotti.
https://github.com/emilim/

Virtual Reality for Supporting the Treatment of Depression and Anxiety: Scoping Review

Conclusions: Most studies demonstrated the use of VR to be effective for supporting the treatment of anxiety or depression in a range of settings and recommended its potential as a tool for use in a clinical environment. Even though standalone headsets are much easier to work with and more suitable for home use, the shift from tethered VR headsets to standalone headsets in the mental health environment was not observed. All studies that looked at the use of CBT either in vivo or in a virtual environment found it to be effective in supporting the treatment of anxiety or depression.

Keywords: CBT; anxiety; depression; mental health; virtual reality.

©Nilufar Baghaei, Vibhav Chitale, Andrej Hlasnik, Lehan Stemmet, Hai-Ning Liang, Richard Porter. Originally published in JMIR Mental Health (https://mental.jmir.org), 23.09.2021.

GENETIC ENGINEERING & BIOTECHNOLOGY in the Future (2077 & Beyond)

What happens when humans begin combining biology with technology, harnessing the power to recode life itself.

What does the future of biotechnology look like? How will humans program biology to create organ farm technology and bio-robots. And what happens when companies begin investing in advanced bio-printing, artificial wombs, and cybernetic prosthetic limbs.

Other topic include: bioengineered food and farming, bio-printing in space, new age living bioarchitecture (eco concrete inspired by coral reefs), bioengineered bioluminescence, cyberpunks and biopunks who experiment underground — creating new age food and pets, the future of bionics, corporations owning bionic limbs, the multi-trillion dollar industry of bio-robots, and bioengineered humans with super powers (Neo-Humans).

As well as the future of biomedical engineering, biochemistry, and biodiversity.
_______

Created by: Jacob.
Narration by: Alexander Masters (www.alexander-masters.com)

Modern Science Fiction.

Continue reading “GENETIC ENGINEERING & BIOTECHNOLOGY in the Future (2077 & Beyond)” | >

The biological switch that could turn neuroplasticity on and off in the brain

The Conversation Weekly podcast is taking a short break in August. In the meantime, we’re bringing you extended versions of some of our favourite interviews from the past few months.

This week, how researchers discovered a biological switch that could turn on and off neuroplasticity in the brain – the ability of neurons to change their structure. We speak to Sarah Ackerman, a postdoctoral fellow at the Institute of Neuroscience and Howard Hughes Medical Institute at the University of Oregon, about what she and her team have found and why it matters.

This episode of The Conversation Weekly features an extended version of an interview first published on April 29. The Conversation Weekly is produced by Mend Mariwany and Gemma Ware, with sound design by Eloise Stevens. Our theme music is by Neeta Sarl. You can sign up to The Conversation’s free daily email here. Full credits for this episode available here.

Further reading: Astrocyte cells in the fruit fly brain are an on-off switch that controls when neurons can change and grow, by Sarah DeGenova Ackerman, University of OregonSwimming gives your brain a boost – but scientists don’t know yet why it’s better than other aerobic activities, by Seena Mathew, University of Mary Hardin-BaylorWhat is brain plasticity and why is it so important?, by Duncan Banks, The Open University.

The Nano Robots Inside You

Inside of you, at all times, there are trillions of natural nano robots walking around, taking out the trash, and packaging strands of DNA. Below the calm, ordered exterior of a living organism lies a complex collection of molecular machines working together to create something greater than themselves. Physicist and author of “Life’s Ratchet” Peter Hoffmann shows us the tiny city beneath the surface.

Watch the full program here: https://youtu.be/FzFY5ms3AUc.
Original program date: May 30, 2013

The World Science Festival gathers great minds in science and the arts to produce live and digital content that allows a broad general audience to engage with scientific discoveries. Our mission is to cultivate a general public informed by science, inspired by its wonder, convinced of its value, and prepared to engage with its implications for the future.

Visit our Website: http://www.worldsciencefestival.com/
Like us on Facebook: https://www.facebook.com/worldsciencefestival.
Follow us on twitter: https://twitter.com/WorldSciFest

Discovered an aging “brake pedal”?

How does the research conducted by Lige Leng at the Institute of Neuroscience of Xiamen University in China (I link it to you here)? It all starts with the study of the “inflamed brain”: many diseases of old age are associated with low-level chronic inflammation in the brain, organs, joints and circulatory system. A phenomenon sometimes called “inflammaging”.

You know it: over time all of our body’s repair systems deteriorate, our DNA and proteins accumulate damage, metabolism stumbles and cells stop doing their job. That’s life, beauty.

We’re all on our way to the exit, but research on worms, flies, mice and monkeys show that going at this speed isn’t inevitable. Diet and lifestyle changes (and, perhaps, upcoming anti-aging drugs) can curb decay and give us many more years of life, especially healthy life.

A new discovery suggests that a protein in the brain could be a switch to control inflammation and, with it, many symptoms and consequences of aging. If scientists can figure out how to distribute it safely in humans, we will finally put the first major brake on the aging process.

Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging

Several factors contribute to the development of inflamm-aging, including genetic susceptibility, visceral obesity, microbiota and gut permeability, cellular senescence, NLRP3 inflammasome activation, oxidative stress caused by mitochondrial dysfunction, immune cells dysregulation, and chronic infection (Ferrucci & Fabbri, 2018). The immune system becomes gradually dysregulated during aging, leading to elevated blood levels of pro-inflammatory mediators, such as TNFα, IL6, and C-reactive protein (Harris et al., 1999 ; Mooradian et al., 1991). Energy homeostasis also becomes dysregulated with aging, which results in the redistribution of subcutaneous fat to visceral regions and contributes to inflammation (Bouchard et al., 1993 ; Chumlea et al., 1989 ; Curtis et al., 2005). Metabolism-induced inflammation, also known as metaflammation, shares similarities with inflamm-aging, including the elevation of certain circulating pro-inflammatory cytokines (Prattichizzo et al., 2018). Therefore, the molecules that play a key role in the regulation of metabolic homeostasis potentially mediate the development of chronic inflammation during aging.

Forkhead box O1 (FOXO1) transcription factor has been indicated to be involved in the regulation of nutrient metabolism and energy homeostasis (Cheng et al., 2009 ; InSug et al., 2015 ; Matsumoto et al., 2007 ; Yang et al., 2019 ; Zhang et al., 2012). Deletion of hepatic Foxo1 improves glucose homeostasis in insulin resistant mice (Dong et al., 2008). FOXO1 inhibition by AS1842856 attenuates hepatic steatosis in diet-induced obesity mice (Ding et al., 2020). In mature macrophages, FOXO1 promotes inflammation through the activation of TLR4-and STAT6-mediated signaling pathways (Fan et al., 2010 ; Lee et al., 2022). In invertebrates, DAF-16, the Foxo homolog gene, mediates the effect of insulin/IGF signaling on lifespan (Ogg et al., 1997). Overexpression of FOXO in Drosophila and C.elegans increases their lifespan (Giannakou et al., 2004 ; Henderson & Johnson, 2001). However, studies in mammalians show that FOXO1 does not have a significant correlation with longevity (Chiba et al., 2009 ; Kleindorp et al., 2011). Considering the role of FOXO1 in regulating glucose metabolism and inflammation, we hypothesize that FOXO1 plays an important role in the regulation of aging-induced inflammation and dysregulation of glucose homeostasis.

Liver is an important metabolic organ that plays a key role in maintaining whole-body nutrient homeostasis by regulating energy metabolism, clearing xenobiotic and endobiotic, and synthesizing necessary molecules (Rui, 2014). As a result, aging-induced changes in liver contribute to systemic susceptibility to aging-related diseases. Different types of liver cells, including hepatocytes, endothelial cells, hepatic stellate cells (HSC), and macrophages, are all affected by the aging process (Hunt et al., 2019). However, most studies on liver aging focused on whole-liver tissue, which is mainly composed of parenchymal cells, hepatocytes. Thus, the effects of aging on liver nonparenchymal cells (NPCs) are less understood. In this study, we used bulk RNA-Seq and single-cell RNA (scRNA)-Seq technologies to analyze aging-induced changes, and the role of FOXO1 in aging-related processes in both whole-liver and individual liver cells, particularly liver macrophages. We found that insulin resistance, liver fat accumulation, liver inflammation, and systemic inflammation were significantly aggravated in old mice. Additionally, aging significantly increased pro-inflammatory response in Kupffer cells (KCs) and induced a functional quiescence in monocyte-derived macrophages (MDMs). FOXO1 activity was significantly enhanced in the livers of old mice and FOXO1 inhibition improved insulin resistance, hepatic steatosis, and inflammation in old mice. Furthermore, we found that FOXO1 inhibition attenuated aging-induced pro-inflammation in KCs and had a limited effect on aging-induced functional quiescence in MDMs. Taken together, this study indicates that FOXO1 plays an important role in the liver aging processes and suggests that FOXO1 is a potential therapeutic target for the treatment of aging-induced chronic diseases.

Scientists develop finger sweat test to detect antipsychotic drugs in patients

Antipsychotic drugs treat incredibly vulnerable patients. Maintaining a treatment regimen is difficult for many patients, but not taking the medication is associated with a higher risk of poor health outcomes. These drugs are also very powerful with strong side effects, and blood tests are often used to calibrate a patient’s dosage and confirm that they are taking the recommended dose.

However, blood tests are invasive and potentially uncomfortable. Scientists have now discovered a way to test the levels of common in the sweat from patients’ fingerprints, offering a quicker, more comfortable, and more convenient alternative to blood draws for patient monitoring.

“Our test offers patients a quick and dignified way of showing commitment to antipsychotic treatment,” said Katherine Longman of the University of Surrey, first author of the study in Frontiers in Chemistry. “This non-invasive approach can also be adapted to fit other therapeutic regimes.”